antigen < antigenic < antigenically

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by antigenic

Number of relevant bibliographic references: 223.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000274 (2019)	M. Linster [Pays-Bas, Singapour] ; E. J. A. Schrauwen [Pays-Bas] ; S. Van Der Vliet [Pays-Bas] ; D. F. Burke [Royaume-Uni] ; P. Lexmond [Pays-Bas] ; T. M. Bestebroer [Pays-Bas] ; D. J. Smith [Royaume-Uni] ; S. Herfst [Pays-Bas] ; B. F. Koel [Pays-Bas] ; R. A. M. Fouchier [Pays-Bas]	The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses
000295 (2019)	Adoraci N Navarro-Torné ; Finnian Hanrahan ; Barbara Kerstiëns ; Pilar Aguar ; Line Matthiessen	Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.
000298 (2019)	Taylor Kain ; Robert Fowler	Preparing intensive care for the next pandemic influenza
000338 (2019)	Min Z. Levine [États-Unis] ; Crystal Holiday [États-Unis] ; Stacie Jefferson [États-Unis] ; F. Liaini Gross [États-Unis] ; Feng Liu [États-Unis] ; Sheng Li [États-Unis] ; Damien Friel [Belgique] ; Philippe Boutet [Belgique] ; Bruce L. Innis [États-Unis] ; Corey P. Mallett [États-Unis] ; Terrence M. Tumpey [États-Unis] ; James Stevens [États-Unis] ; Jacqueline M. Katz [États-Unis]	Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost
000450 (2018)	Rose T. Byrne-Nash ; David F. Miller ; Katie M. Bueter ; Jacob H. Gillis ; Laura R. Kuck ; Kathy L. Rowlen	VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
000454 (2018)	John S. Oxford [Royaume-Uni] ; Douglas Gill [Royaume-Uni]	Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself.
000506 (2018)	Maarten Van Wijhe [Danemark] ; Mathias M Lbak Ingholt [Danemark] ; Viggo Andreasen [Danemark] ; Lone Simonsen [Danemark]	Loose Ends in the Epidemiology of the 1918 Pandemic: Explaining the Extreme Mortality Risk in Young Adults.
000512 (2018)	Florian Krammer [États-Unis] ; Gavin J. D. Smith [Singapour, États-Unis] ; Ron A. M. Fouchier [Pays-Bas] ; Malik Peiris [République populaire de Chine] ; Katherine Kedzierska ; Peter C. Doherty [États-Unis] ; Peter Palese [États-Unis] ; Megan L. Shaw [États-Unis] ; John Treanor [États-Unis] ; Robert G. Webster [États-Unis] ; Adolfo García-Sastre [États-Unis]	Influenza
000533 (2018)	Sarder Mohammed Asaduzzaman [Canada] ; Junling Ma [Canada] ; P. Van Den Driessche [Canada]	Estimation of Cross-Immunity Between Drifted Strains of Influenza A/H3N2.
000555 (2018)	B. Henry	Canada’s Pandemic Influenza Preparedness: Laboratory strategy
000602 (2017-09-06)	Gwladys Monamele [Cameroun] ; Marie-Astrid Vernet [Cameroun] ; Mohammed Njankouo [Cameroun] ; Kathleen Victoir [France] ; Jane Akoachere [Cameroun] ; Damian Anong [Cameroun] ; Richard Njouom [Cameroun]	Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons
000638 (2017)	Sai V. Vemula [États-Unis] ; Ekramy E. Sayedahmed [États-Unis] ; Suryaprakash Sambhara [États-Unis] ; Suresh K. Mittal [États-Unis]	Vaccine approaches conferring cross-protection against influenza viruses
000666 (2017)	Mizuho Suzuki ; Masatoshi Okamatsu ; Takahiro Hiono ; Keita Matsuno ; Yoshihiro Sakoda	Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice
000678 (2017)	Ruiying Zhang [République populaire de Chine] ; Chongfeng Xu [République populaire de Chine] ; Ziyuan Duan [République populaire de Chine]	Novel antigenic shift in HA sequences of H1N1 viruses detected by big data analysis.
000708 (2017)	Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis]	Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice
000711 (2017)	Ee Hui Goh [Singapour] ; Lili Jiang [Singapour] ; Jung Pu Hsu [Singapour] ; Linda Wei Lin Tan [Singapour] ; Wei Yen Lim [Singapour] ; Meng Chee Phoon [Singapour] ; Yee Sin Leo ; Ian G. Barr [Australie] ; Vincent Tak Kwong Chow [Singapour] ; Vernon J. Lee [Singapour] ; Cui Lin [Singapour] ; Raymond Lin [Singapour] ; Sapna P. Sadarangani ; Barnaby Young ; Mark I-Cheng Chen [Singapour]	Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010
000742 (2017)	Zenglei Hu [République populaire de Chine] ; Xinan Jiao [République populaire de Chine] ; Xiufan Liu [République populaire de Chine]	Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design
000832 (2016)	Rahul Subramanian [États-Unis] ; Andrea L. Graham [États-Unis] ; Bryan T. Grenfell [États-Unis] ; Nimalan Arinaminpathy [Royaume-Uni]	Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines
000881 (2016)	Zhimin Wan [République populaire de Chine] ; Jianqiang Ye [République populaire de Chine] ; Jianjun Sang [République populaire de Chine] ; Hongxia Shao [République populaire de Chine] ; Kun Qian [République populaire de Chine] ; Wenjie Jin [République populaire de Chine] ; Aijian Qin [République populaire de Chine] ; Hongquan Wan [République populaire de Chine]	Identification of amino acids in H9N2 influenza virus neuraminidase that are critical for the binding of two mouse monoclonal antibodies.
000960 (2016)	Tatyana Ilyicheva [Russie] ; Murat Abdurashitov [Russie] ; Alexander Durymanov [Russie] ; Ivan Susloparov [Russie] ; Natalya Goncharova [Russie] ; Natalya Kolosova [Russie] ; Valery Mikheev [Russie] ; Alexander Ryzhikov [Russie]	Herd immunity and fatal cases of influenza among the population exposed to poultry and wild birds in Russian Asia in 2013–2014
000981 (2016)	Wei Yu [République populaire de Chine] ; Fan Yang [République populaire de Chine] ; Jinghui Yang [République populaire de Chine] ; Lei Ma [République populaire de Chine] ; Yina Cun [République populaire de Chine] ; Shaohui Song [République populaire de Chine] ; Guoyang Liao [République populaire de Chine]	Construction high‐yield candidate influenza vaccine viruses in Vero cells by reassortment

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "antigenic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "antigenic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    antigenic
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021